The stock price of Metlife Inc (NYSE: MET) has jumped by 0.83 compared to previous close of 80.42. Despite this, the company has seen a gain of 1.80% in its stock price over the last five trading days. businesswire.com reported 2025-07-01 that NEW YORK–(BUSINESS WIRE)–MetLife, Inc., General Atlantic, and Chariot Reinsurance, Ltd. (Chariot Re), an independent Bermuda-based Class E life and annuity reinsurance company, today announced the completion of Chariot Re’s initial reinsurance transaction with a subsidiary of MetLife. Chariot Re will reinsure approximately $10 billion of liabilities, including structured settlement annuity contracts and group annuity contracts associated with pension risk transfers originated by MetLife. Char.
Is It Worth Investing in Metlife Inc (NYSE: MET) Right Now?
Metlife Inc (NYSE: MET) has a price-to-earnings ratio of 13.20x that is above its average ratio. Additionally, the 36-month beta value for MET is 0.83. There are mixed opinions on the stock, with 7 analysts rating it as a “buy,” 5 rating it as “overweight,” 4 rating it as “hold,” and 0 rating it as “sell.”
The public float for MET is 561.51M and currently, short sellers hold a 1.41% ratio of that float. The average trading volume of MET on July 02, 2025 was 3.43M shares.
MET’s Market Performance
MET’s stock has seen a 1.80% increase for the week, with a 3.19% rise in the past month and a 1.00% gain in the past quarter. The volatility ratio for the week is 1.34%, and the volatility levels for the past 30 days are at 1.52% for Metlife Inc. The simple moving average for the past 20 days is 2.31% for MET’s stock, with a -0.00% simple moving average for the past 200 days.
Analysts’ Opinion of MET
Many brokerage firms have already submitted their reports for MET stocks, with BMO Capital Markets repeating the rating for MET by listing it as a “Market Perform.” The predicted price for MET in the upcoming period, according to BMO Capital Markets is $97 based on the research report published on January 23, 2025 of the current year 2025.
TD Cowen, on the other hand, stated in their research note that they expect to see MET reach a price target of $97. The rating they have provided for MET stocks is “Buy” according to the report published on October 09th, 2024.
Barclays gave a rating of “Overweight” to MET, setting the target price at $91 in the report published on September 05th of the previous year.
MET Trading at 3.66% from the 50-Day Moving Average
After a stumble in the market that brought MET to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -8.94% of loss for the given period.
Stock Fundamentals for MET
Current profitability levels for the company are sitting at:
- 0.09 for the present operating margin
- 1.0 for the gross margin
The net margin for Metlife Inc stands at 0.06. The total capital return value is set at 0.01. Equity return is now at value 16.08, with 0.66 for asset returns.
Based on Metlife Inc (MET), the company’s capital structure generated 0.35 points at debt to capital in total, while cash flow to debt ratio is standing at 1.13. The debt to equity ratio resting at 0.55. The interest coverage ratio of the stock is 6.25.
Currently, EBITDA for the company is 7.37 billion with net debt to EBITDA at -2.12. When we switch over and look at the enterprise to sales, we see a ratio of 0.66. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.13.
Conclusion
In conclusion, Metlife Inc (MET) has seen better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
